Bevacizumab AVAiLs in non-small cell lung cancer

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1593, 2007-01, pp. : 15-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bevacizumab in Non-Small Cell Lung Cancer

By Francesco Di Costanzo

Drugs, Vol. 68, Iss. 6, 2008-01 ,pp. : 737-746

Adis International

Access to resources Recommend Favorite

Bowel perforation in non-small cell lung cancer after bevacizumab therapy

By Schellhaas Elisabeth Loddenkemper Christoph Schmittel Alexander Buhr Heinz-J. Pohlen Uwe

Investigational New Drugs, Vol. 27, Iss. 2, 2009-04 ,pp. : 184-187

Springer Publishing Company

Access to resources Recommend Favorite

Non–Small Cell Lung Cancer

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 3, 2008-03 ,pp. : 228-228

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

First-line bevacizumab, cisplatin and vinorelbine plus maintenance bevacizumab in advanced non-squamous non-small cell lung cancer chemo-naïve patients

By Leon Luis Vázquez Sergio Gracia José Manuel Casal Joaquín Lazaro Martín Firvida José Luis Amenedo Margarita Santome Lucia Macia Sonia

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 10, 2012-07 ,pp. : 1389-1396

Informa Healthcare

Access to resources Recommend Favorite

Bevacizumab in Non Small Cell Lung Cancer: Development, Current Status and Issues

Current Medicinal Chemistry, Vol. 19, Iss. 7, 2012-03 ,pp. : 961-971

Bentham Science Publishers

Access to resources Recommend Favorite